BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19080799)

  • 1. Quantitative analysis of mast cells in benign and malignant colonic lesions: immunohistochemical study on formalin-fixed, paraffin-embedded tissues.
    Kashiwase Y; Inamura H; Morioka J; Igarashi Y; Kawai-Kowase K; Kurosawa M
    Allergol Immunopathol (Madr); 2008; 36(5):271-6. PubMed ID: 19080799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of mast cells in benign and malignant breast lesions. Immunohistochemical study on formalin-fixed, paraffin-embedded tissues.
    Kashiwase Y; Morioka J; Inamura H; Yoshizawa Y; Usui R; Kurosawa M
    Int Arch Allergy Immunol; 2004 Jul; 134(3):199-205. PubMed ID: 15178888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cells and eosinophils are involved in activation of ulcerative colitis.
    Stasikowska-Kanicka O; Danilewicz M; Głowacka A; Wągrowska-Danilewicz M
    Adv Med Sci; 2012; 57(2):230-6. PubMed ID: 22968338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric DNA analysis of ulcerative colitis using paraffin-embedded biopsy specimens: comparison with morphology and DNA analysis of fresh samples.
    Hartmann DP; Montgomery EA; Carr NJ; Gupta PK; Azumi N
    Am J Gastroenterol; 1995 Apr; 90(4):590-6. PubMed ID: 7717317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated glycoprotein (TAG-72) expression in ulcerative colitis.
    Thor A; Itzkowitz SH; Schlom J; Kim YS; Hanauer S
    Int J Cancer; 1989 May; 43(5):810-5. PubMed ID: 2654025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical demonstration of carcinoembryonic antigen in normal, transitional and inflamed colonic mucosa.
    Wagener C; Hain F; Breuer H; Olude S; Cremer H; Müller-Wallraf R
    Oncodev Biol Med; 1981; 2(5):331-43. PubMed ID: 7036104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between Colon Cells and Macrophages Increases ST6GALNAC1 and MUC1-sTn Expression in Ulcerative Colitis and Colitis-Associated Colon Cancer.
    Kvorjak M; Ahmed Y; Miller ML; Sriram R; Coronnello C; Hashash JG; Hartman DJ; Telmer CA; Miskov-Zivanov N; Finn OJ; Cascio S
    Cancer Immunol Res; 2020 Feb; 8(2):167-178. PubMed ID: 31831633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue demonstration of carcinoembryonic antigen (CEA) in ulcerative colitis.
    Isaacson P
    Gut; 1976 Jul; 17(7):561-7. PubMed ID: 964689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells in ulcerative colitis. Quantitative and ultrastructural studies.
    Balázs M; Illyés G; Vadász G
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 57(6):353-60. PubMed ID: 2575298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis.
    King T; Biddle W; Bhatia P; Moore J; Miner PB
    Dig Dis Sci; 1992 Apr; 37(4):490-5. PubMed ID: 1551335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoperoxidase staining for CEA in ulcerative colitis.
    Friedman CJ; Mills SE
    J Clin Gastroenterol; 1983 Oct; 5(5):453-9. PubMed ID: 6355271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of tumor-associated glycoprotein DF3 in normal, inflammatory, and neoplastic lesions of the colon.
    Andrews CW; Jessup JM; Goldman H; Hayes DF; Kufe DW; O'Hara CJ; Steele GD
    Cancer; 1993 Dec; 72(11):3185-90. PubMed ID: 7694786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of HLA-DR antigens by colonic epithelium in ulcerative colitis].
    Radwan P; Słomka M; Skrzydło-Radomańska B
    Pol Arch Med Wewn; 1992 Jun; 87(6):358-64. PubMed ID: 1384005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mast cells in ulcerative colitis].
    Balázs M; Illyés G; Vadász G
    Morphol Igazsagugyi Orv Sz; 1989 Jul; 29(3):161-9. PubMed ID: 2797015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of colonic natural killer cells, large granular lymphocytes and mast cells in inflammatory bowel disease.
    Emmons LR; Schaub U; Hadziselimovic F
    Adv Exp Med Biol; 1995; 371B():1261-6. PubMed ID: 7502796
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunohistochemical evaluation of carcinoembryonic antigen, secretory component, and epithelial IgA in ulcerative colitis with dysplasia.
    Rognum TO; Elgjo K; Fausa O; Brandtzaeg P
    Gut; 1982 Feb; 23(2):123-33. PubMed ID: 7040173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
    Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
    Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulcerative colitis--a disease characterised by the abnormal colonic epithelial cell?
    Gibson PR; van de Pol E; Barratt PJ; Doe WF
    Gut; 1988 Apr; 29(4):516-21. PubMed ID: 3371720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do mast cells play a pathogenetic role in neurofibromatosis type 1 and ulcerative colitis?
    Baratelli F; Le M; Gershman GB; French SW
    Exp Mol Pathol; 2014 Apr; 96(2):230-4. PubMed ID: 24583366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.